{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:57:42Z","timestamp":1787003862708,"version":"build-2736575974"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2007,4,5]],"date-time":"2007-04-05T00:00:00Z","timestamp":1175731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,4,5]],"date-time":"2007-04-05T00:00:00Z","timestamp":1175731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1038\/sj.leu.2404682","type":"journal-article","created":{"date-parts":[[2007,4,5]],"date-time":"2007-04-05T05:26:28Z","timestamp":1175750788000},"page":"1545-1548","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":89,"title":["A different schedule of zoledronic acid can reduce the risk of the osteonecrosis of the jaw in patients with multiple myeloma"],"prefix":"10.1038","volume":"21","author":[{"given":"A","family":"Corso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Varettoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Zappasodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Klersy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Mangiacavalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Pica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Lazzarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,4,5]]},"reference":[{"key":"BF2404682_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4065\/78.1.21","volume":"78","author":"RA Kyle","year":"2003","unstructured":"Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 2003; 78: 21\u201333.","journal-title":"Mayo Clin Proc"},{"key":"BF2404682_CR2","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.bcmd.2004.01.001","volume":"32","author":"GD Roodman","year":"2004","unstructured":"Roodman GD . Pathogenesis of myeloma bone disease. Blood Cells Mol Dis 2004; 32: 290\u2013292.","journal-title":"Blood Cells Mol Dis"},{"key":"BF2404682_CR3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0305-7372(93)90028-P","volume":"19","author":"RE Coleman","year":"1993","unstructured":"Coleman RE, Purohit OP . Osteoclast inhibition for the treatment of bone metastases. Cancer Treat Rev 1993; 19: 79\u2013103.","journal-title":"Cancer Treat Rev"},{"key":"BF2404682_CR4","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1056\/NEJM199602223340802","volume":"334","author":"JR Berenson","year":"1996","unstructured":"Berenson JR, Lichtenstein A, Porter L, Dimopoulos MA, Bordoni R, George S et al. Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. N Engl J Med 1996; 334: 488\u2013493.","journal-title":"N Engl J Med"},{"key":"BF2404682_CR5","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1200\/JCO.1998.16.2.593","volume":"16","author":"JR Berenson","year":"1998","unstructured":"Berenson JR, Lichtenstein A, Porter L, Dimopoulos MA, Bordoni R, George S et al. Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group. J Clin Oncol 1998; 16: 593\u2013602.","journal-title":"J Clin Oncol"},{"key":"BF2404682_CR6","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/jbmr.5650090521","volume":"9","author":"JR Green","year":"1994","unstructured":"Green JR, Muller K, Jaeggi KA . preclinical pharmacology of CGP 42'446, a new, potent heterocyclic bisphosphonate compound. J Bone Miner Res 1994; 9: 745\u2013751.","journal-title":"J Bone Miner Res"},{"key":"BF2404682_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0093-7754(01)90261-1","volume":"28","author":"PP Major","year":"2001","unstructured":"Major PP, Coleman RE . Zoledronic acid in the treatment of hypercalcemia of malignancy: results of the international clinical development program. Semin Oncol 2001; 28: 17\u201324.","journal-title":"Semin Oncol"},{"key":"BF2404682_CR8","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1002\/cncr.11701","volume":"98","author":"LS Rosen","year":"2003","unstructured":"Rosen LS, Gordon D, Kaminski M, Howell A, Belch A, Mackey J et al. Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma. Cancer 2003; 98: 1735\u20131744.","journal-title":"Cancer"},{"key":"BF2404682_CR9","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE . Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003; 61: 1115\u20131117.","journal-title":"J Oral Maxillofac Surg"},{"key":"BF2404682_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1056\/NEJM200507073530120","volume":"353","author":"BG Durie","year":"2005","unstructured":"Durie BG, Katz M, Crowley J . Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 2005; 353: 99\u2013102.","journal-title":"N Engl J Med"},{"key":"BF2404682_CR11","doi-asserted-by":"publisher","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","volume":"23","author":"A Bamias","year":"2005","unstructured":"Bamias A, Kastritis E, Bamia C, Moulopoulos LA, Melakopoulos I, Bozas G et al. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 2005; 23: 8580\u20138587.","journal-title":"J Clin Oncol"},{"key":"BF2404682_CR12","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1200\/JCO.2005.04.2465","volume":"24","author":"A Badros","year":"2006","unstructured":"Badros A, Weikel D, Salama A, Goloubeva O, Schneider A, Rapoport A et al. Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J Clin Oncol 2006; 24: 945\u2013952.","journal-title":"J Clin Oncol"},{"key":"BF2404682_CR13","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1200\/JCO.2002.06.037","volume":"20","author":"JR Berenson","year":"2002","unstructured":"Berenson JR, Hillner BE, Kyle RA, Anderson K, Lipton A, Yee GC et al. American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma. J Clin Oncol 2002; 20: 3719\u20133736.","journal-title":"J Clin Oncol"},{"key":"BF2404682_CR14","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.4065\/81.8.1047","volume":"81","author":"MQ Lacy","year":"2006","unstructured":"Lacy MQ, Dispensieri A, Gertz MA, Greipp PR, Gollbach KL, Hayman SR et al. Mayo Clinic Consensus Statement for the use of bisphosphonates in multiple myeloma. Mayo Clin Proc 2006; 81: 1047\u20131053.","journal-title":"Mayo Clin Proc"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2404682.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404682","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404682.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T22:20:53Z","timestamp":1648765253000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2404682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,5]]},"references-count":14,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["BF2404682"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2404682","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1079822.532746","asserted-by":"object"}]},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,5]]},"assertion":[{"value":"22 November 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}